Epstein-barr Virus Infection
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]
This clinical trial update covers Phase 1/2 testing of allogeneic virus-specific cytotoxic T-lymphocytes for adenovirus and Epstein-Barr vir…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess ou…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China [Phase 1]
This is a Phase 1 clinical trial in China evaluating virus-specific cytotoxic T lymphocytes to prophylactically prevent and therapeutically …
-
CLINICAL_TRIALS withdrawal · 2016-01-21Clinical Trial Update: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
A clinical trial evaluating allogeneic virus-specific cytotoxic T-lymphocytes for persistent or recurrent EBV, CMV, and adenoviral infection…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
This completed clinical trial evaluated Epstein-Barr virus infections as a risk factor for post-transplant lymphoproliferative disorder in p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]
Phase 1 trial update on VIRAGE, rapidly generated multivirus-specific cytotoxic T-lymphocytes, for viral infections in the context of stem c…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes following a CD45 antibody in patients with EBV-positive nasopharyngeal carcino…
-
CLINICAL_TRIALS research · 2011-12-22Clinical Trial Update: Modified Vaccinia Ankara (MVA) Vaccine Study [Phase 1]
A Phase 1 study of a Modified Vaccinia Ankara (MVA) vaccine for nasopharyngeal carcinoma and Epstein-Barr virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Surveillance Study of Viral Infections Following Lung Transplantation
Completed surveillance trial examining viral infections in lung transplant recipients, including Epstein-Barr virus and paramyxoviridae infe…
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Clinical trial update examining the prevalence of cytomegalovirus, Epstein-Barr virus, and HHV-6 in the saliva of a patient with periodontit…
-
CLINICAL_TRIALS trial_result · 2007-02-02Clinical Trial Update: Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664). [Phase 2]
Phase 2 trial update evaluating safety, immune response, and efficacy of GSK's Epstein-Barr virus vaccine in Epstein-Barr virus infection.